Health Condition 1: J988- Other specified respiratory disorders
Conditions
Interventions
Intervention1: Individualized Homoeopathic Medicine: Indicated individualized
homoeopathic medicine will be
prescribed after the
repertorisation of the case using rubrics within Complete
repertory. Do
Sponsors
National Institute of Homoeopathy
Eligibility
Inclusion criteria
Inclusion criteria: 1.Participants above 14 years of age to 70 years of age from any socio-economic status and religions who can understand either Bengali or Hindi or English and willing to voluntarily participate in the study, after regular follow-up assessment and adhere to the prescribed homoeopathic treatment plan shall be enrolled in the study. 2. Participants fulfilling the clinical diagnostic criteria of chronic rhinosinusitis: Symptoms persisting for greater than 12 weeks. At least 2 of the 4 cardinal symptoms: nasal obstruction,congestion, nasal discharge (anterior,postnasal drip), facial pain,pressure,fullness, or reduction,loss of smell. One of the symptoms must be nasal obstruction or nasal discharge. 3. Participants fulfilling the diagnostic features of the Hydrogenoid constitution, as per Grauvogl’s constitution assessed through screening form for Grauvogl’s Hydrogenoid constitution. If they say ‘yes’ to more than 10 criteria (out of 17 criteria) they will be included in the study. 4. The presenting complaint or constitutional traits should have been persisting for at least 3 months, to rule out acute,temporary symptomatology.
Exclusion criteria
Exclusion criteria: 1. Individuals with overlapping, undefined, or confused hydrogenoid constitution, making analysis difficult. 2. Participants diagnosed with the complications (mucous retention cyst, orbital cellulitis, meningitis, brain abscess etc.) of CRS. 3. Pregnant and lactating mothers. 4. Participants with drug abuse/drug dependence. 5. Currently suffering from severe, acute, or life-threatening illnesses, immunocompromised or diagnosed psychiatric conditions.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The evaluation of participant response and changes will be conducted utilizing the Sino-Nasal Outcome Test 22 (SNOT-22), a disease specific participant reported outcome measure. The Sino-Nasal Outcome Test 22 (SNOT-22) score is derived from responses collected at the baseline and after 6 months period of treatment with homoeopathic medicines selected using Complete repertory. The data collected over six months will help to evaluate the impact of individualised homoeopathic medicines in participant of Grauvogl’s Hydrogenoid constitution.Timepoint: Baseline and 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| NilTimepoint: Nil | — |
Countries
India
Contacts
Public ContactDr Lokanath Behera
National Institute of Homoeopathy
Outcome results
None listed